Loading experience…
The Sonogen device is not cleared by FDA and is not available for sale in the United States.
Learn More
Supported by
Our Device
Ultrasonic therapy
Web App
Mobile app
Explore Our Product
Learn more about How it Works
Sonogen's device is designed to deliver low-intensity pulsed ultrasound (LIPUS), a therapy with more than 30 years of clinical use in fracture healing.
Learn More
Sonogen is developing Ultrasonic Fracture Assessment (UFA) to explore what ultrasound echoes can reveal about fracture healing. The technology is being developed to analyze ultrasound data using digital signal processing and neural networks.
Ultrasonic Fracture Assessment (UFA) is a separate product in development. It is not part of the Sonogen bone growth stimulator and has not been cleared or approved by FDA.
Learn More
About Us
Bone fractures are a prevalent medical concern, affecting millions worldwide annually. The healing process of such injuries can be complex, involving various physiological stages that can be significantly influenced by external factors.
Learn More
Bone fractures typically undergo a well-orchestrated healing process involving inflammation, repair, and remodeling. However, in certain instances, this process is disrupted, leading to delayed union or nonunion of the fracture.
Learn More
Join our mailing list for company news and product updates.
Thank you for signing up! Your request has been received.
We couldn’t submit your sign-up. Please try again or email info@sonogenmed.com.
Certain product images and animations on this website were created or enhanced using AI and are illustrative. They may differ from physical prototypes or final products.